Key facts
- This page summarizes Funicular Fund, LP's Form 4 filing for ARCA biopharma, Inc. (ORKA).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 May 2022, 17:12.
Funicular Fund, LP - 23 May 2022 Form 4 Insider Report for ARCA biopharma, Inc. (ORKA)
- Reporting relationship
- Other*
- Issuer ticker
- ORKA
- Reported as of
- 23 May 2022
- Net transaction value
- +$197,404
- SEC form
- 4
- Accepted by SEC
- 25 May 2022, 17:12:15 UTC
- Prior SEC filing
- 20 May 2022
- Source filing
- View source filing
- Reporting owner signature
- Funicular Fund, LP, By: Cable Car Capital LLC, its general partner, By: /s/ Jacob Ma-Weaver, Managing Member
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Funicular Fund, LP filed Form 4 for ARCA biopharma, Inc. (ORKA) on 25 May 2022.
Change
- Previous filing in this sequence was filed on 20 May 2022.
- Current net transaction value: +$197,404.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ABIO
transaction
Common Stock
Purchase
- Transaction value
- $5,281
- Shares
- +2,301
- Change %
- +0.09%
- Price
- $2.30
- Shares after
- 2,497,491
- Date
- 23 May 2022
- Ownership
- Direct
- Footnotes
- F1, F2
ABIO
transaction
Common Stock
Purchase
- Transaction value
- $41,383
- Shares
- +18,110
- Change %
- +0.73%
- Price
- $2.29
- Shares after
- 2,515,601
- Date
- 24 May 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F3
ABIO
transaction
Common Stock
Purchase
- Transaction value
- $150,740
- Shares
- +64,851
- Change %
- +2.6%
- Price
- $2.32
- Shares after
- 2,580,452
- Date
- 25 May 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ABIO
holding
Derivative
Put Option (obligation to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 14,500
- Date
- 23 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,450,000
- Exercise price
- $2.50
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
Footnote F2
Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.
Footnote F3
Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2850 to $2.2950, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
Footnote F4
Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2550 to $2.3450, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.